Background
Pulmonary fibrosis (PF), especially idiopathic pulmonary fibrosis (IPF), is a chronic lung disease caused by several factors. IPF exhibits a complex pathogenesis, but no effective treatment is available for IPF. The mortality rate of IPF is considerably increased in recent years, and it substantially threatens human health [
1,
2]. Current treatments for IPF, such as immunosuppressants (e.g., cyclophosphamide), are limited by low their efficacy and severe side effects. The FDA recently approved two new drugs, nintedanib and pirfenidone, to treat IPF. These drugs stabilize patients’ conditions well, but they do not reverse the progression of fibrosis. Both drugs produce side effects on the liver and skin, which limits their clinical application, especially in patients with liver problems [
3,
4]. Recent research demonstrated that dexamethasone (DEX) attenuated bleomycin (BLM)-induced lung fibrosis [
5]. However, DEX treatment produces many side effects, such as growth retardation, hyperglycemia, hypertension, myocardial hypertrophy, gastrointestinal perforation, and neurological impairment [
6‐
8]. Therefore, new drugs with improved treatment efficacy and fewer side effects are urgently needed.
IPF is easily characterized by an excessive deposition of extracellular matrix (ECM), but the pathogenesis of IPF is not clear. Several hypotheses were proposed to explain the inner mechanisms, and epithelial–mesenchymal transition (EMT) of alveolar epithelial cells (AECs) received particular attention. Nuclear factor kappa-B (NF-κB) is an essential mediator of EMT. NF-κB promotes the transcription of many inflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukin (IL) and transforming growth factor β (TGF-β), which are highly associated with the progression of IPF, especially TGF-β [
9‐
11]. Therefore, it is essential to measure these factors when evaluating the drug efficacy of IPF.
Parthenolide (PTL) is a sesquiterpene lactone that is isolated from the shoots of feverfew (
Tanacetum parthenium), and PTL is a traditional medicinal herb used for headaches and arthritis. Recent studies suggested that PTL is a useful antitumor and anti-inflammatory agent, and it was tested in clinical studies for leukemia and neurological tumors [
12]. These biological activities of PTL in tumor and inflammatory diseases primarily occur via inhibition of NF-κB and the targeting of multiple steps in the NF-κB signaling pathway. For example, PTL binds an activator of NF-κB, IκB-kinase (IKK) [
13]. However, PTL treatment of IPF and its pharmacological properties have not been reported.
The present study found that PTL attenuated BLM-induced EMT-related protein expression and inhibited IPF-associated cytokines, which supports PTL as a potential compound for IPF treatment.
Methods
Reagents
PTL (> 99%) was provided by Shangdeyaoyuan Co. (Tianjin, China). DEX sodium phosphate (> 98.5%) was purchased from Meilun Biological Technology Co. (Dalian, China), and BLM sulfate (> 91%) was obtained from Meilun Biological Technology Co. (Dalian, China). The NF-κB, Snail, β-actin, GAPDH, E-cadherin, vimentin, MMP1, α-SMA and Col-1 antibodies were purchased from Affinity Biosciences Co. (Beijing, China). The mouse TNF-α, mouse IL-4, mouse TGF-β1, and mouse interferon gamma ELISA Kits were purchased from Meilian Biological Technology Co. (Shanghai, China). Chlorine ammonia T (> 97.08%) and p-dimethylaminobenzaldehyde (> 97.08%) were obtained from (> 99.71%). Reverse-4-hydroxy-l-proline (> 99.4%) was purchased from Bailingwei Technology Co. (Beijing, China). Perchloric acid (> 70%) was obtained from Jingchun Biological Technology Co. (Shanghai, China).
Cell culture
The human pulmonary epithelial A549 cell line was obtained from KeyGen Biotech (Nanjing, China). The human fetal lung fibroblast cell line HFL1 was kindly supplied by Professor Wen Ning (Nankai University). The cells were cultured in a medium supplemented with 10% heat-inactivated (56 °C, 30 min) fetal calf serum (HyClone, USA) and maintained at 37 °C with 5% CO2 in a humidified atmosphere.
Isolation of primary fibroblasts and AECs
Primary pulmonary fibroblasts isolated from NaCl/BLM-treated mice were cultured in DMEM supplemented with 10% FBS and antibiotics in 5% CO2 at 37 °C in a humidified atmosphere as described previously [
14]. Cells at passages 3–4 were used for cell viability and wound healing assays. Primary AECs were isolated from C57BL/6 J mice as previously described [
15]. Newly isolated AECs were used for immunofluorescence and Western blotting assays.
Cell viability and wound-healing assays
Cell viability was determined using the MTT assay. Cells (5 × 103 cells/mL) were seeded in 96-well culture plates and incubated overnight. Cells were treated with various concentrations of PTL for 24 h. Cell viability was measured after the addition of MTT (20 μL) at 37 °C for 4 h. Dimethyl sulfoxide (150 μL) was added to dissolve the formazan crystals. Optical density was measured at 570 nm using a microplate reader (Multiskan FC, Thermo Scientific, Waltham, MA, USA).
Cells for the wound healing assay were grown on a 35-mm dish to 100% confluency and scraped to form a 100-μm wound using sterile pipette tips. The cells were cultured in the presence or absence of PTL in serum-free media for 24 h. Images of the cells were obtained at 24 h using a light microscope (Nikon, Japan).
Immunofluorescence
Primary epithelial cells were fixed in 4% paraformaldehyde for 20 min, washed with PBS, permeabilized with 0.2% Triton X-100 in PBS, blocked with 5% BSA and incubated with E-cadherin and vimentin antibodies. Cells were washed with PBS, and donkey anti-rabbit Fluor 555 or donkey anti-mouse Fluor 488 secondary antibodies (CWBIO, China) were used for immunofluorescence visualization. The nucleus was labeled with DAPI (Solarbio, China), and cells were photographed with a TCS SP5 confocal (Leica) microscope.
Dual luciferase assay
AP1, STAT3, NF-κB, snail, slug and MYC promoters were cloned into the pGL6-TA luciferase reporter vector, and A549 cells were transfected with luciferase reporter plasmids using Lipofectamine (Invitrogen). Renilla-luciferase was used as an internal control. Cells were treated 1 d after transfection with 5 μΜ (L) or 10 μM (H) PTL for 24 h. Cells were harvested, and the luciferase activity of cell lysates was determined using a luciferase assay system (Promega) as described by the manufacturer. Total light emission was measured using a Luminoskan Ascent Reader System (Thermo, Massachusetts, USA).
BLM-induced PF in mice
Specific pathogen-free ICR mice (males) (body weights 18–22 g) were purchased from the Laboratory Animal Center, Academy of Military Medical Sciences of People’s Liberation Army (Beijing, China) and housed in groups of six under a regular 12-h light/dark cycle. Mice were acclimated to laboratory conditions for one week prior to testing at a constant temperature.
Sixty mice were divided into six groups with 10 animals per group according to body weight: control group, BLM group, BLM + DEX group (0.45 mg/kg), BLM + PTL-H group (50 mg/kg), BLM + PTL-M group (25 mg/kg), and BLM + PTL-L group (12.5 mg/kg). PF was established in mice via a single intratracheal administration of BLM at 5 mg/kg body weight. Different doses of PTL were intragastrically administered daily for four weeks beginning 7 days after BLM injury, and DEX was used as the positive control. Control and model groups received an equal volume of vehicle (0.9% NaCl) using the same schedule and route of administration.
Mouse body weights were recorded daily. Mice were sacrificed on the 36th day using excess chloral hydrate hydrochloride anesthesia. Blood was obtained for ELISA analyses, and whole lungs were removed and weighed. The right lungs were fixed in 10% formalin, dehydrated, and embedded in paraffin. The left lungs were used to determine hydroxyproline. The pulmonary coefficient was calculated using the following equation: lung weight/body weight × 100%.
Hydroxyproline assay
Collagen contents in left lungs of each group were measured using a conventional hydroxyproline method [
15]. The results were confirmed via measurement of samples containing known amounts of purified collagen.
Evaluation of pulmonary function
Mice were anesthetized with 10% chloral hydrate in NaCl (i.p.) and transferred to a plethysmographic chamber for pulmonary function analyses using the Anires2005 system (Beijing Biolab, Beijing, China). This system automatically calculates and displays pulmonary function parameters, including dynamic compliance and inspiratory and expiratory resistance.
Histopathological examination
Paraffin sections were prepared at a 4-μm thickness, stained with H&E and Masson’s trichrome using the manufacturers’ standard procedures, and observed under a photomicroscope (Olympus, Tokyo, Japan) for microscopic examination of morphological changes and fibrosis evaluation (collagen fibers).
Immunohistochemistry
The tissue sections were pretreated in a microwave, blocked and incubated using a series of antibodies, and stained with DAB and hematoxylin. The results were captured using a microscope (Olympus, Japan). The intensity and percentage of positive cells were measured. Multiplication (staining index) of intensity and percentage scores was used to determine the results.
Plasma collection
Mice were anesthetized, and a microhematocrit tube was introduced to the canthus of the orbit. The microhematocrit tube was slightly advanced and rotated to allow blood flow into the lithium-heparin tube. Plasma was separated from the cellular fraction via centrifugation at 3500 rpm for 10 min at 4 °C and stored at − 80 °C.
Bronchoalveolar lavage fluid (BALF) collection and cell counts
The tracheas of mice were cannulated and lavaged three times with 1-ml sterile PBS at room temperature for BALF collection. Samples were centrifuged at 1000 rpm for 5 min, and cell pellets were recovered in 1-ml sterile PBS. Cells were counted using a hemocytometer. Smears of BALF cells were stained with hematoxylin and eosin and viewed under light microscopy to measure the inflammatory cell differential.
TGF-β1, TNF-α and IL-4 assays
Plasma TGF-β1, TNF-α and IL-4 levels were assayed using ELISA Kits (Shanghai Enzyme-linked Biotechnology Co., Ltd., Shanghai, China). Assays were performed according to the manufacturer’s instructions.
Statistical analysis
Data are presented as the means ± standard deviation. Significant differences between treatment groups were detected using one-way ANOVA. All analyses were performed using SPSS 17.0 statistical software. P < 0.05 was considered statistically significant.
Discussion
PTL is a natural molecule that was originally isolated from the shoots of feverfew (
Tanacetum parthenium). PTL exhibits excellent anti-inflammatory and antitumor activities [
16,
17]. The first written records of the anti-inflammatory effect of PTL were provided in 1597 in Europe [
18]. PTL from
Magnolia grandiflora exhibited antitumor properties for the first time in 1973 [
19]. The biological properties of PTL were primarily attributed to the strong inhibition of NF-κB and the targeting of various steps within the NF-κB signaling pathway [
20,
21].
The inflammatory response during the initial phase of PF damages the ECM and produces numerous FBs via activation of the repair mechanism. The relationship between PF and cytokines, particularly TNF-α and TGF-β, attracted considerable attention in recent years. These cytokines promote inflammation progression [
22‐
24]. NF-κB is commonly activated to protect against organisms, but disorder in its activation is related to chronic inflammation [
25]. PTL inhibited the activities of TNF-α, TGF-β, and NF-κB in the present study.
Our studies evaluated the role of PTL in PF. The results demonstrated that PTL repressed BLM-induced pulmonary fibrosis in mice. PTL inhibited EMT of AECs, which upregulate epithelial marker expression and downregulate the expression of mesenchymal markers. We evaluated the influence of PTL on AP-1, NF-κB, STAT-3, Snail, Slug and c-Myc expression. PTL only downregulated NF-κB and Snail. The NF-κB pathway regulates Snail expression via transcriptional and post-translational mechanisms. NF-κB binds to the human Snail promoter and increases Snail transcription. Our results demonstrated that NF-κB and Snail expression levels and activities decreased following PTL treatment. Therefore, PTL may inhibit the NF-κB signaling pathway and exhibit proinflammatory effects during PF.
FBs are important in the structural formation process and maintaining the function of pulmonary tissues [
26]. The cross talk of FBs and AECs promotes fibrosis. FBs proliferate continuously as a result of multiple factors, such as the stimulating action of cytokines [
27‐
29]. Therefore, an effective approach to inhibit FB proliferation in PF should be urgently identified [
30]. The present results demonstrated that PTL inhibited the proliferation and migration of primary pulmonary fibroblasts and HFL1 cells in a dose-dependent manner.
EMT is an indispensable step in numerous diseases, and it induces cell changes involved in pathological processes, such as fibrosis [
31,
32]. EMT plays a pivotal role in the development of PF. Lung epithelial cells are a frequent target of injury, a driver of normal repair, and a key element in the pathobiology of fibrotic lung diseases. One important aspect of epithelial cells is their capacity to respond to microenvironmental cues by undergoing EMT. EMT regulates a series of critical signaling elements that produce proinflammatory signals and cause cell injury. EMT is not the widespread conversion of epithelial cells to FBs, but it is a graded response whereby epithelial cells reversibly acquire mesenchymal features and enhance the capacity for mesenchymal cross talk [
33]. Repeated injury superimposes persistent inflammation and hypoxia in these highly regulated repair pathways, which potentially overwhelms the orderly repair to create sustained fibrogenesis [
34]. Our results suggest that PTL inhibited PF via inhibition of EMT. PTL increased the expression level of E-cad and reduced vimentin levels in TGF-β1-treated primary lung epithelial cells. NF-κB and Snail levels decreased significantly in the PTL treatment groups in a dose-dependent manner.
The potential signaling pathways involved in PTL treatment were analyzed using the STRING database and GO analysis. PTL affected many functions, including the inflammatory response, proliferation, molecular function, cell structure, and biological processes. These biological processes were closely related to pulmonary fibrosis.